Clinical trial
A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant…
NCT00330915 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00330915 |
|---|---|
| Title | A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. |
| Official title | A Feasibility Study of Pemetrexed Single Agent and Folic Acid Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Neoplasms |
| Intervention type | Drug |
| Interventions | pemetrexed |
| Enrollment | 37 |
| Start date | Jun 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | May 29, 2006 |
| Last update posted | Jul 21, 2009 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: